BlossomHill Therapeutics, Inc. Common Stock Net Asset Quality Index
BlossomHill Therapeutics, Inc. Common Stock net asset quality index. BlossomHill Therapeutics, Inc. Common Stock (BLSM) has a Net Asset Quality Index of -106.1% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $143.41 Million minus total liabilities of $295.53 Million yields net assets of $-152.12 Million. A higher index indicates a stronger, lower-leverage balance sheet. See what is BlossomHill Therapeutics, Inc. Common St's book value for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of BlossomHill Therapeutics, Inc. Common Stock (2024–2025)
Net asset quality index of BlossomHill Therapeutics, Inc. Common Stock from 2024 to 2025. This chart shows how BlossomHill Therapeutics, Inc. Common Stock's Net Asset Quality Index has evolved across 2 annual periods from 2024 to 2025. As of March 2026, the index stands at -106.1%, representing net assets of $-152.12 Million against total assets of $143.41 Million USD. See BlossomHill Therapeutics, Inc. Common St (BLSM) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
BlossomHill Therapeutics, Inc. Common Stock Net Asset Quality Index by Year (2024–2025)
BlossomHill Therapeutics, Inc. Common Stock net asset quality index by year from 2024 to 2025. The table below presents the year-by-year Net Asset Quality Index for BlossomHill Therapeutics, Inc. Common Stock from 2024 to 2025, covering 2 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market cap of BlossomHill Therapeutics, Inc. Common St.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | -80.8% | $-131.73 Million | $162.97 Million | $294.70 Million | ▼ -12.6 pp |
| 2024 | -68.3% | $-72.88 Million | $106.78 Million | $179.66 Million | — |